Aryx Therapeutics I Stock Total Asset
| ARYXDelisted Stock | USD 0.0005 0.00 0.00% |
Aryx Therapeutics I fundamentals help investors to digest information that contributes to Aryx Therapeutics' financial success or failures. It also enables traders to predict the movement of Aryx Pink Sheet. The fundamental analysis module provides a way to measure Aryx Therapeutics' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Aryx Therapeutics pink sheet.
Aryx |
Aryx Therapeutics I Company Total Asset Analysis
Aryx Therapeutics' Total Asset is everything that a business owns. It is the sum of current and long-term assets owned by a firm at a given time. These assets are listed on a balance sheet and typically valued based on their purchasing prices, not the current market value.
Current Aryx Therapeutics Total Asset | 12.41 M |
Most of Aryx Therapeutics' fundamental indicators, such as Total Asset, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Aryx Therapeutics I is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Total Asset is typically divided on the balance sheet on current asset and long-term asset. Long-term is the value of company property and other capital assets that are expected to be useable for more than one year. Long term assets are reported net of depreciation. On the other hand current assets are assets that are expected to be sold or converted to cash as part of normal business operation.
CompetitionBased on the latest financial disclosure, Aryx Therapeutics I has a Total Asset of 12.41 M. This is 99.84% lower than that of the Pharmaceuticals sector and significantly higher than that of the Health Care industry. The total asset for all United States stocks is 99.96% higher than that of the company.
Aryx Total Asset Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Aryx Therapeutics' direct or indirect competition against its Total Asset to detect undervalued stocks with similar characteristics or determine the pink sheets which would be a good addition to a portfolio. Peer analysis of Aryx Therapeutics could also be used in its relative valuation, which is a method of valuing Aryx Therapeutics by comparing valuation metrics of similar companies.Aryx Therapeutics is currently under evaluation in total asset category among its peers.
Aryx Fundamentals
| Return On Asset | -0.75 | ||||
| Current Valuation | 237.58 K | ||||
| Shares Outstanding | 33.46 M | ||||
| Shares Owned By Institutions | 0.14 % | ||||
| Number Of Shares Shorted | 89.05 K | ||||
| Price To Book | 37.83 X | ||||
| EBITDA | (14.18 M) | ||||
| Net Income | (33.17 M) | ||||
| Cash And Equivalents | 2.95 M | ||||
| Cash Per Share | 0.09 X | ||||
| Debt To Equity | (5.11) % | ||||
| Current Ratio | 0.47 X | ||||
| Book Value Per Share | (0.23) X | ||||
| Cash Flow From Operations | (34.97 M) | ||||
| Short Ratio | 0.79 X | ||||
| Earnings Per Share | (0.59) X | ||||
| Target Price | 1.5 | ||||
| Number Of Employees | 56 | ||||
| Beta | 0.0896 | ||||
| Market Capitalization | 237.58 K | ||||
| Total Asset | 12.41 M | ||||
| Retained Earnings | (187.11 M) | ||||
| Working Capital | 126 K | ||||
| Current Asset | 8.62 M | ||||
| Current Liabilities | 8.49 M | ||||
| Z Score | -24.3 | ||||
| Net Asset | 12.41 M |
About Aryx Therapeutics Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Aryx Therapeutics I's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Aryx Therapeutics using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Aryx Therapeutics I based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in manufacturing. You can also try the Instant Ratings module to determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Other Consideration for investing in Aryx Pink Sheet
If you are still planning to invest in Aryx Therapeutics check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Aryx Therapeutics' history and understand the potential risks before investing.
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance |